MediPoint: Prosthetic Heart Valves - Current and Future Players


#281144

N/A

GlobalData

$ 3500

In Stock


The global prosthetic heart valves (PHV) market is a dynamic, billion-dollar market that is saturated with numerous players developing innovative technologies. Recent advancements in the field of interventional cardiology have greatly expanded the potential of therapeutic applications. Prosthetic heart valves, including mechanical valves, tissue valves, and transcatheter valves, can be used to treat patients with valvular heart disease affecting the aortic or mitral valves. They can be delivered either via open-heart surgery or transcatheter aortic valve implantation (TAVR).

The rising prevalence of disease and associated risk factors, an aging population, and improved clinical outcomes with minimally invasive techniques are expected to drive the growth of the global prosthetic heart valve market. Emerging technologies such as repositionable and retrievable transcatheter aortic valves will optimize clinical outcomes for patients. With improvements in the design of transcatheter valves, they have the potential to become the standard of treatment for valvular heart disease in the future.

The report provides up-to-date information and in-depth analysis on the key players that shape this market. This includes an analysis of company market shares, industry trends, and corporate strategy. This report is built using data and information sourced from secondary sources and primary research interviews with leading Interventional Cardiologists, with in-house analysis conducted by GlobalDatas team of industry experts.

Highlights

Key Benefits

What Physicians Think quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading Interventional Cardiologists and Cardiac Surgeons from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Scope

  • Investigation of current and future market competition for prosthetic heart valves.
  • Competitive Assessment including device approval analysis.
  • Coverage of key market players and company profiles including business description, financial overview, product portfolio assessment, and SWOT analysis.
  • Strategic Assessment of the market through market impact analysis, future market scenario, and company analysis.

Reasons to buy

  • Gain a high level view of the trends shaping and driving the PHV market.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape.
  • Take a comprehensive look at the markets device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
Table of Contents

1 Table of Contents
1.1 List of Tables

2 Introduction
2.1 Anatomy
2.2 Epidemiology
2.3 Related Reports

3 Competitive Assessment
3.1 Overview
3.2 Classification Based on Features
3.2.1 Mechanical Heart Valves
3.2.2 Tissue Heart Valves
3.2.3 Transcatheter Heart Valves
3.3 Market Dynamics Analysis
3.4 Product Profiles
3.4.1 Mechanical Heart Valves
3.4.2 Tissue Heart Valves
3.4.3 Transcatheter Heart Valves

4 Pipeline Assessment
4.1 Overview
4.2 Product Profiles
4.2.1 Cytograft Tissue Valve (Cytograft Tissue Engineering)
4.2.2 Centera Valve (Edwards Lifesciences)
4.2.3 Colibri Heart Valve (Colibri Heart Valve)
4.2.4 Cormove (Perouse Medical)
4.2.5 Endovalve (Micro Interventional Devices)
4.2.6 HLT Transcatheter Valve System (Heart Leaflet Technology)
4.2.7 Inovare Valve (Braile Biomdica)
4.2.8 Kalangos Valve (Leman Cardiovascular)
4.2.9 Tiara Valve (Neovasc)
4.2.10 Trinity Valve (Transcatheter Technologies GmbH)
4.2.11 Vanguard Exchangeable Heart Valve System (ValveXchange)

5 Current and Future Players
5.1 Overview
5.2 Trends in Corporate Strategy
5.3 Company Profiles
5.3.1 AorTech International
5.3.2 Boston Scientific
5.3.3 Braile Biomdica
5.3.4 CardiAQ Valve Technologies
5.3.5 Claret Medical
5.3.6 Colibri Heart Valve
5.3.7 Cytograft Tissue Engineering
5.3.8 Direct Flow Medical
5.3.9 Edwards Lifesciences
5.3.10 Heart Leaflet Technologies
5.3.11 JenaValve Technology
5.3.12 Leman Cardiovascular
5.3.13 Micro Interventional Devices
5.3.14 Neovasc
5.3.15 On-X Life Technologies, Inc.
5.3.16 Perouse Medical
5.3.17 Sorin Group
5.3.18 St. Jude Medical
5.3.19 Symetis
5.3.20 Transcatheter Technologies GmbH
5.3.21 TTK Healthcare
5.3.22 ValveXchange

6 Appendix
6.1 Bibliography
6.2 Abbreviations
6.3 Report Methodology
6.3.1 Overview
6.3.2 Coverage
6.3.3 Secondary Research
6.4 Forecasting Methodology
6.5 Physicians and Specialists Included in This Study
6.6 About the Authors
6.6.1 Analysts
6.6.2 Global Head of Healthcare
6.7 About GlobalData
6.8 Disclaimer

Table 1: Mechanical Heart Valves, SWOT Analysis, 2014
Table 2: Marketed Mechanical Heart Valve Products, 2014
Table 3: Tissue Heart Valves, SWOT Analysis, 2014
Table 4: Marketed Tissue Heart Valve Products, 2014
Table 5: Transcatheter Heart Valves, SWOT Analysis, 2014
Table 6: Marketed Transcatheter Heart Valve Products, 2014
Table 7: Product Profile - Carbomedics Standard Aortic Mechanical Valve (Sorin Group)
Table 8: Carbomedics Standard Aortic Mechanical Valve, SWOT Analysis, 2014
Table 9: Product Profile - Open Pivot Mechanical Valve (Medtronic)
Table 10: Open Pivot Mechanical Valve, SWOT Analysis, 2014
Table 11: Product Profile - On-X Mechanical Heart Valve (On-X Life Technologies)
Table 12: On-X Mechanical Heart Valve, SWOT Analysis, 2014
Table 13: Product Profile - On-X Plus 1.5 Mechanical Heart Valve (On-X Life Technologies)
Table 14: On-X Plus 1.5 Mechanical Heart Valve, SWOT Analysis, 2014
Table 15: Product Profile - Regent Valve (St. Jude Medical)
Table 16: Regent Valve, SWOT Analysis, 2014
Table 17: Product Profile - Carpentier-Edwards Perimount Pericardial Valve (Edwards Lifesciences)
Table 18: Carpentier-Edwards Perimount Pericardial Valve, SWOT Analysis, 2014
Table 19: Product Profile - 3f Enable Sutureless Aortic Bioprosthesis (Medtronic)
Table 20: 3f Enable Sutureless Aortic Bioprosthesis, SWOT Analysis, 2014
Table 21: Product Profile - Hancock II (Medtronic)
Table 22: Medtronic Hancock II, SWOT Analysis, 2014
Table 23: Product Profile - Mitroflow Aortic Pericardial Heart Valve (Sorin Group)
Table 24: Sorin Group Mitroflow Aortic Pericardial Heart Valve, SWOT Analysis, 2014
Table 25: Product Profile - Trifecta Heart Valve (St. Jude Medical)
Table 26: St. Jude Medical Trifecta Heart Valve, SWOT Analysis, 2014
Table 27: Product Profile - Acurate TA/Acurate neo (Symetis)
Table 28: Acurate TA/Acurate neo, SWOT Analysis, 2014
Table 29: Product Profile - Lotus Valve System (Boston Scientific)
Table 30: Boston Scientific Lotus Valve System, SWOT Analysis, 2014
Table 31: Product Profile - Direct Flow Medical Transcatheter Valve (Direct Flow Medical)
Table 32: Direct Flow Medical Valve, SWOT Analysis, 2014
Table 33: Product Profile - Sapien XT Valve (Edwards Lifesciences)
Table 34: Sapien XT Valve, SWOT Analysis, 2014
Table 35: Product Profile - JenaValve (JenaValve Technology)
Table 36: JenaValve, SWOT Analysis, 2014
Table 37: Product Profile - CoreValve (Medtronic)
Table 38: Product Profile - CoreValve Evolut R (Medtronic)
Table 39: CoreValve Evolut R, SWOT Analysis, 2014
Table 40: Product Profile - Portico Valve (St. Jude Medical)
Table 41: Portico Valve, SWOT Analysis, 2014
Table 42: Product Profile - Cytograft Tissue Valve (Cytograft Tissue Engineering)
Table 43: Cytograft Tissue Valve, SWOT Analysis, 2014
Table 44: Product Profile - Centera Valve (Edwards Lifesciences Corporation)
Table 45: Centera Valve, SWOT Analysis, 2014
Table 46: Product Profile - Colibri Heart Valve (Colibri Heart Valve)
Table 47: Colibri Heart Valve, SWOT Analysis, 2014
Table 48: Product Profile - Cormove (Perouse Medical)
Table 49: Cormove, SWOT Analysis, 2014
Table 50: Product Profile - Endovalve (Micro Interventional Devices)
Table 51: Endovalve, SWOT Analysis, 2014
Table 52: Product Profile - HLT Transcatheter Valve System (Heart Leaflet Technology)
Table 53: HLT Transcatheter Valve System, SWOT Analysis, 2014
Table 54: Product Profile - Inovare Valve (Braile Biomdica)
Table 55: Inovare Valve, SWOT Analysis, 2014
Table 56: Product Profile - Kalangos Valve (Leman Cardiovascular)
Table 57: Kalangos Valve, SWOT Analysis, 2014
Table 58: Product Profile - Tiara Valve (Neovasc.)
Table 59: Tiara Valve, SWOT Analysis, 2014
Table 60: Product Profile - Trinity Valve (Transcatheter Technologies GmbH)
Table 61: Trinity VALVE, SWOT Analysis, 2014
Table 62: Product Profile - Vanguard Exchangeable Heart Valve System (ValveXchange)
Table 63: Vanguard Exchangeable Heart Valve System, SWOT Analysis, 2014
Table 64: AorTech International plc, Company Profile, 2014
Table 65: AorTech International, SWOT Analysis, 2014
Table 66: Boston Scientific Corporation, Company Profile, 2014
Table 67: Boston Scientific Corporation, SWOT Analysis, 2014
Table 68: Braile Biomdica, Company Profile, 2014
Table 69: Braile Biomdica, SWOT Analysis, 2014
Table 70: CardiAQ Valve Technologies, Company Profile, 2014
Table 71: CardiAQ Valve Technologies, SWOT Analysis, 2014
Table 72: Claret Medical, Inc., Company Profile, 2014
Table 73: Claret Medical, SWOT Analysis, 2014
Table 74: Colibri Heart Valve, LLC, Company Profile, 2014
Table 75: Colibri Heart Valve, SWOT Analysis, 2014
Table 76: Cytograft Tissue Engineering, Inc., Company Profile, 2014
Table 77: Cytograft Tissue Engineering, SWOT Analysis, 2014
Table 78: Direct Flow Medical, Inc., Company Profile, 2014
Table 79: Direct Flow Medical, SWOT Analysis, 2014
Table 80: Edwards Lifesciences Corporation, Company Profile, 2014
Table 81: Edwards Lifesciences, SWOT Analysis, 2014
Table 82: Heart Leaflet Technologies, Company Profile, 2014
Table 83: Heart Leaflet Technologies, SWOT Analysis, 2014
Table 84: JenaValve Technology, Company Profile, 2014
Table 85: JenaValve Technology, SWOT Analysis, 2014
Table 86: Leman Cardiovascular, Company Profile, 2014
Table 87: Leman Cardiovascular, SWOT Analysis, 2014
Table 88: Micro Interventional Devices, Inc., Company Profile, 2014
Table 89: Micro Interventional Devices, SWOT Analysis, 2014
Table 90: Neovasc, Inc., Company Profile, 2014
Table 91: Neovasc, SWOT Analysis, 2014
Table 92: On-X Life Technologies, Inc., Company Profile, 2014
Table 93: On-X Life Technologies, SWOT Analysis, 2014
Table 94: Perouse Medical, Company Profile, 2014
Table 95: Perouse Medical, SWOT Analysis, 2014
Table 96: Sorin Group, Company Profile, 2014
Table 97: Sorin Group, SWOT Analysis, 2014
Table 98: St. Jude Medical, Inc., Company Profile, 2014
Table 99: St. Jude Medical, Inc., SWOT Analysis, 2014
Table 100: Symetis, Company Profile, 2014
Table 101: Symetis, SWOT Analysis, 2014
Table 102: Transcatheter Technologies GmbH, Company Profile, 2014
Table 103: Transcatheter Technologies, SWOT Analysis, 2014
Table 104: TTK Healthcare, Company Profile, 2014
Table 105: TTK Healthcare, SWOT Analysis, 2014
Table 106: ValveXchange, Inc., Company Profile, 2014
Table 107: ValveXchange, SWOT Analysis, 2014